Central cyanosis due to severe pulmonary hypertension combined with pericarditis as the initial manifestation of systemic lupus erythematosus

American Journal of Emergency Medicine

Volumn 26, Issue 2, 2008, Pages 248.e1-248.e2

  Wang, Ruei Fang ^a   Hung, Tzu Yao ^a   Chong, Chee Fah ^a,b   Wang, Tzong Luen ^a,b   Chen, Chien Chih ^a,b  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; C REACTIVE PROTEIN; METHYLPREDNISOLONE; STEROID;

ADULT; ARTERIAL GAS; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CYANOSIS; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; EMERGENCY WARD; FEMALE; HUMAN; JUGULAR VEIN; LABORATORY TEST; LUNG ARTERY PRESSURE; OXYGEN MASK; OXYGEN SATURATION; PERICARDITIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULSE OXIMETRY; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 38949096359     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2007.04.007     Document Type: Article

References (14)

1. Wallace D.J. The clinical presentation of systemic lupus erythematosus. In: Wallace D.J., and Hahn B.H. (Eds). Dubois' lupus erythematosus. 5th ed. (1997), Lippincott Wilkins and Wilkins, Baltimore 627
2. Smith E.L., and Rhmerling S. The American College of Rheumatology criteria for the classification of systemic lupus erythematosus. Strengths, weaknesses and opportunities for improvement. Lupus 8 (1999) 586-595
3. Perez H.D., and Kramer N. Pulmonary hypertension in systemic lupus erythematosus: report of four cases and review of the literature. Semin Arthritis Rheum 11 (1981) 177-181
4. Quismorio Jr. F.P., Sharma O., Koss M., et al. Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin Arthritis Rheum 13 (1984) 349-359
5. Winslow T.M., Ossipov M.A., Fazio G.P., et al. Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J 129 (1995) 510-515
6. Pan T.L., Thumboo J., and Boey M.L. Primary and secondary pulmonary hypertension in systemic lupus erythematosus. Lupus 9 (2000) 338-342
7. Tanaka E., Harigai M., Tanaka M., et al. Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment. J Rheumatol 29 (2002) 282-287
8. Pines A., Kaplinsky N., Olchovsky D., et al. Pleuro-pulmonary manifestations of systemic lupus erythematosus: clinical features of its subgroups. Chest 88 (1985) 129-135
9. Goupille P., Fauchier L., Babuty D., et al. Precapillary pulmonary hypertension dramatically improved with high doses of corticosteroids during systemic lupus erythematosus. J Rheumatol 21 (1994) 1976-1977
10. Medsger T.A. Pulmonary manifestations. In: Shur P.H. (Ed). The clinical management of systemic lupus erythematosus (1996), Lippencott-Raven, New York 89
11. Chung S.M., Lee C.K., Lee E.Y., et al. Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension. Clin Rheumatol 25 (2006) 866-872
12. Kim W.U., Min J.K., Lee S.H., et al. Causes of death in Korean patients with systemic lupus erythematosus: a single center retrospective study. Clin Exp Rheumatol 17 (1999) 539-545
13. Gonzalez-Lopez L., Cardona-Munoz E.G., Celis A., et al. Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematosus. Lupus 13 (2004) 105-112
14. Rubin L.J., Badesch D.B., Barst R.J., et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346 (2002) 896-903